Showing results (41-50 of 392) with videos related to
Sort By:
Pageof 40
Human Gene Therapy|December 6, 2019
Specific Overexpression of Mitofusin-2 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in Mice ModelHanzhang Zhu, Yuqiang Shan, Ke Ge, et al.Heliyon|May 30, 2024
Optical frequency multiplication using residual network with random forest regressionQi Zhang, Xu Han, Xinyu Fang, et al.Biological Chemistry|February 14, 2021
C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1)Yafeng Wan, Ke Ge, Weijiang Zhou, et al.Clinical and Experimental Medicine|December 1, 2018
Meta-analysis of FOLFIRINOX regimen as the first-line chemotherapy for locally advanced pancreatic cancer and borderline resectable pancreatic cancerXifeng Xu, Qiong Wu, Zhen Wang, et al.Scandinavian Journal of Gastroenterology|January 18, 2021
EIF3B promotes cancer progression in pancreatic cancerHanzhang Zhu, Yuqiang Shan, Ke Ge, et al.International Journal of Molecular Sciences|October 27, 2022
CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer ProgressionHanzhang Zhu, Weijiang Zhou, Yafeng Wan, et al.Biofactors (Oxford, England)|March 7, 2022
Light-activatable multifunctional paclitaxel nanoprodrug for synergistic chemo-photodynamic therapy in liver cancerHanzhang Zhu, Weijiang Zhou, Yafeng Wan, et al.Cellular Oncology (Dordrecht, Netherlands)|August 16, 2020
Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapyHanzhang Zhu, Yuqiang Shan, Ke Ge, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 1, 2020
LncRNA CYTOR promotes pancreatic cancer cell proliferation and migration by sponging miR-205-5pHanzhang Zhu, Yuqing Shan, Ke Ge, et al.World Journal of Surgical Oncology|October 9, 2019
Selective occlusion of the hepatic artery and portal vein improves liver hypertrophy for staged hepatectomyChangku Jia, Ke Ge, Sunbing Xu, et al.Pageof 40